Global Gene Therapy On Cardiovascular Disease Market Insights and Forecast to 2028

Global Gene Therapy On Cardiovascular Disease Market Insights and Forecast to 2028

Table of Contents
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gene Therapy On Cardiovascular Disease Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Viral Gene Therapy
1.2.3 Non-Viral Gene Therapy
1.3 Market by Application
1.3.1 Global Gene Therapy On Cardiovascular Disease Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Heart Disease
1.3.3 Vascular Disease
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Gene Therapy On Cardiovascular Disease Market Perspective (2017-2028)
2.2 Gene Therapy On Cardiovascular Disease Growth Trends by Region
2.2.1 Gene Therapy On Cardiovascular Disease Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Gene Therapy On Cardiovascular Disease Historic Market Size by Region (2017-2022)
2.2.3 Gene Therapy On Cardiovascular Disease Forecasted Market Size by Region (2023-2028)
2.3 Gene Therapy On Cardiovascular Disease Market Dynamics
2.3.1 Gene Therapy On Cardiovascular Disease Industry Trends
2.3.2 Gene Therapy On Cardiovascular Disease Market Drivers
2.3.3 Gene Therapy On Cardiovascular Disease Market Challenges
2.3.4 Gene Therapy On Cardiovascular Disease Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Gene Therapy On Cardiovascular Disease Players by Revenue
3.1.1 Global Top Gene Therapy On Cardiovascular Disease Players by Revenue (2017-2022)
3.1.2 Global Gene Therapy On Cardiovascular Disease Revenue Market Share by Players (2017-2022)
3.2 Global Gene Therapy On Cardiovascular Disease Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Gene Therapy On Cardiovascular Disease Revenue
3.4 Global Gene Therapy On Cardiovascular Disease Market Concentration Ratio
3.4.1 Global Gene Therapy On Cardiovascular Disease Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gene Therapy On Cardiovascular Disease Revenue in 2021
3.5 Gene Therapy On Cardiovascular Disease Key Players Head office and Area Served
3.6 Key Players Gene Therapy On Cardiovascular Disease Product Solution and Service
3.7 Date of Enter into Gene Therapy On Cardiovascular Disease Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Gene Therapy On Cardiovascular Disease Breakdown Data by Type
4.1 Global Gene Therapy On Cardiovascular Disease Historic Market Size by Type (2017-2022)
4.2 Global Gene Therapy On Cardiovascular Disease Forecasted Market Size by Type (2023-2028)
5 Gene Therapy On Cardiovascular Disease Breakdown Data by Application
5.1 Global Gene Therapy On Cardiovascular Disease Historic Market Size by Application (2017-2022)
5.2 Global Gene Therapy On Cardiovascular Disease Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Gene Therapy On Cardiovascular Disease Market Size (2017-2028)
6.2 North America Gene Therapy On Cardiovascular Disease Market Size by Type
6.2.1 North America Gene Therapy On Cardiovascular Disease Market Size by Type (2017-2022)
6.2.2 North America Gene Therapy On Cardiovascular Disease Market Size by Type (2023-2028)
6.2.3 North America Gene Therapy On Cardiovascular Disease Market Share by Type (2017-2028)
6.3 North America Gene Therapy On Cardiovascular Disease Market Size by Application
6.3.1 North America Gene Therapy On Cardiovascular Disease Market Size by Application (2017-2022)
6.3.2 North America Gene Therapy On Cardiovascular Disease Market Size by Application (2023-2028)
6.3.3 North America Gene Therapy On Cardiovascular Disease Market Share by Application (2017-2028)
6.4 North America Gene Therapy On Cardiovascular Disease Market Size by Country
6.4.1 North America Gene Therapy On Cardiovascular Disease Market Size by Country (2017-2022)
6.4.2 North America Gene Therapy On Cardiovascular Disease Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Gene Therapy On Cardiovascular Disease Market Size (2017-2028)
7.2 Europe Gene Therapy On Cardiovascular Disease Market Size by Type
7.2.1 Europe Gene Therapy On Cardiovascular Disease Market Size by Type (2017-2022)
7.2.2 Europe Gene Therapy On Cardiovascular Disease Market Size by Type (2023-2028)
7.2.3 Europe Gene Therapy On Cardiovascular Disease Market Share by Type (2017-2028)
7.3 Europe Gene Therapy On Cardiovascular Disease Market Size by Application
7.3.1 Europe Gene Therapy On Cardiovascular Disease Market Size by Application (2017-2022)
7.3.2 Europe Gene Therapy On Cardiovascular Disease Market Size by Application (2023-2028)
7.3.3 Europe Gene Therapy On Cardiovascular Disease Market Share by Application (2017-2028)
7.4 Europe Gene Therapy On Cardiovascular Disease Market Size by Country
7.4.1 Europe Gene Therapy On Cardiovascular Disease Market Size by Country (2017-2022)
7.4.2 Europe Gene Therapy On Cardiovascular Disease Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Gene Therapy On Cardiovascular Disease Market Size (2017-2028)
8.2 Asia-Pacific Gene Therapy On Cardiovascular Disease Market Size by Type
8.2.1 Asia-Pacific Gene Therapy On Cardiovascular Disease Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Gene Therapy On Cardiovascular Disease Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Gene Therapy On Cardiovascular Disease Market Share by Type (2017-2028)
8.3 Asia-Pacific Gene Therapy On Cardiovascular Disease Market Size by Application
8.3.1 Asia-Pacific Gene Therapy On Cardiovascular Disease Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Gene Therapy On Cardiovascular Disease Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Gene Therapy On Cardiovascular Disease Market Share by Application (2017-2028)
8.4 Asia-Pacific Gene Therapy On Cardiovascular Disease Market Size by Region
8.4.1 Asia-Pacific Gene Therapy On Cardiovascular Disease Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Gene Therapy On Cardiovascular Disease Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Gene Therapy On Cardiovascular Disease Market Size (2017-2028)
9.2 Latin America Gene Therapy On Cardiovascular Disease Market Size by Type
9.2.1 Latin America Gene Therapy On Cardiovascular Disease Market Size by Type (2017-2022)
9.2.2 Latin America Gene Therapy On Cardiovascular Disease Market Size by Type (2023-2028)
9.2.3 Latin America Gene Therapy On Cardiovascular Disease Market Share by Type (2017-2028)
9.3 Latin America Gene Therapy On Cardiovascular Disease Market Size by Application
9.3.1 Latin America Gene Therapy On Cardiovascular Disease Market Size by Application (2017-2022)
9.3.2 Latin America Gene Therapy On Cardiovascular Disease Market Size by Application (2023-2028)
9.3.3 Latin America Gene Therapy On Cardiovascular Disease Market Share by Application (2017-2028)
9.4 Latin America Gene Therapy On Cardiovascular Disease Market Size by Country
9.4.1 Latin America Gene Therapy On Cardiovascular Disease Market Size by Country (2017-2022)
9.4.2 Latin America Gene Therapy On Cardiovascular Disease Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Gene Therapy On Cardiovascular Disease Market Size (2017-2028)
10.2 Middle East & Africa Gene Therapy On Cardiovascular Disease Market Size by Type
10.2.1 Middle East & Africa Gene Therapy On Cardiovascular Disease Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Gene Therapy On Cardiovascular Disease Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Gene Therapy On Cardiovascular Disease Market Share by Type (2017-2028)
10.3 Middle East & Africa Gene Therapy On Cardiovascular Disease Market Size by Application
10.3.1 Middle East & Africa Gene Therapy On Cardiovascular Disease Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Gene Therapy On Cardiovascular Disease Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Gene Therapy On Cardiovascular Disease Market Share by Application (2017-2028)
10.4 Middle East & Africa Gene Therapy On Cardiovascular Disease Market Size by Country
10.4.1 Middle East & Africa Gene Therapy On Cardiovascular Disease Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Gene Therapy On Cardiovascular Disease Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Biogen
11.1.1 Biogen Company Details
11.1.2 Biogen Business Overview
11.1.3 Biogen Gene Therapy On Cardiovascular Disease Introduction
11.1.4 Biogen Revenue in Gene Therapy On Cardiovascular Disease Business (2017-2022)
11.1.5 Biogen Recent Developments
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis Gene Therapy On Cardiovascular Disease Introduction
11.2.4 Novartis Revenue in Gene Therapy On Cardiovascular Disease Business (2017-2022)
11.2.5 Novartis Recent Developments
11.3 Gilead Sciences
11.3.1 Gilead Sciences Company Details
11.3.2 Gilead Sciences Business Overview
11.3.3 Gilead Sciences Gene Therapy On Cardiovascular Disease Introduction
11.3.4 Gilead Sciences Revenue in Gene Therapy On Cardiovascular Disease Business (2017-2022)
11.3.5 Gilead Sciences Recent Developments
11.4 Sarepta Therapeutics
11.4.1 Sarepta Therapeutics Company Details
11.4.2 Sarepta Therapeutics Business Overview
11.4.3 Sarepta Therapeutics Gene Therapy On Cardiovascular Disease Introduction
11.4.4 Sarepta Therapeutics Revenue in Gene Therapy On Cardiovascular Disease Business (2017-2022)
11.4.5 Sarepta Therapeutics Recent Developments
11.5 Alnylam Pharmaceuticals
11.5.1 Alnylam Pharmaceuticals Company Details
11.5.2 Alnylam Pharmaceuticals Business Overview
11.5.3 Alnylam Pharmaceuticals Gene Therapy On Cardiovascular Disease Introduction
11.5.4 Alnylam Pharmaceuticals Revenue in Gene Therapy On Cardiovascular Disease Business (2017-2022)
11.5.5 Alnylam Pharmaceuticals Recent Developments
11.6 Amgen
11.6.1 Amgen Company Details
11.6.2 Amgen Business Overview
11.6.3 Amgen Gene Therapy On Cardiovascular Disease Introduction
11.6.4 Amgen Revenue in Gene Therapy On Cardiovascular Disease Business (2017-2022)
11.6.5 Amgen Recent Developments
11.7 Spark Therapeutics
11.7.1 Spark Therapeutics Company Details
11.7.2 Spark Therapeutics Business Overview
11.7.3 Spark Therapeutics Gene Therapy On Cardiovascular Disease Introduction
11.7.4 Spark Therapeutics Revenue in Gene Therapy On Cardiovascular Disease Business (2017-2022)
11.7.5 Spark Therapeutics Recent Developments
11.8 Akcea Therapeutics
11.8.1 Akcea Therapeutics Company Details
11.8.2 Akcea Therapeutics Business Overview
11.8.3 Akcea Therapeutics Gene Therapy On Cardiovascular Disease Introduction
11.8.4 Akcea Therapeutics Revenue in Gene Therapy On Cardiovascular Disease Business (2017-2022)
11.8.5 Akcea Therapeutics Recent Developments
11.9 bluebird bio
11.9.1 bluebird bio Company Details
11.9.2 bluebird bio Business Overview
11.9.3 bluebird bio Gene Therapy On Cardiovascular Disease Introduction
11.9.4 bluebird bio Revenue in Gene Therapy On Cardiovascular Disease Business (2017-2022)
11.9.5 bluebird bio Recent Developments
11.10 Sunway Biotech
11.10.1 Sunway Biotech Company Details
11.10.2 Sunway Biotech Business Overview
11.10.3 Sunway Biotech Gene Therapy On Cardiovascular Disease Introduction
11.10.4 Sunway Biotech Revenue in Gene Therapy On Cardiovascular Disease Business (2017-2022)
11.10.5 Sunway Biotech Recent Developments
11.11 SIBIONO
11.11.1 SIBIONO Company Details
11.11.2 SIBIONO Business Overview
11.11.3 SIBIONO Gene Therapy On Cardiovascular Disease Introduction
11.11.4 SIBIONO Revenue in Gene Therapy On Cardiovascular Disease Business (2017-2022)
11.11.5 SIBIONO Recent Developments
11.12 AnGes
11.12.1 AnGes Company Details
11.12.2 AnGes Business Overview
11.12.3 AnGes Gene Therapy On Cardiovascular Disease Introduction
11.12.4 AnGes Revenue in Gene Therapy On Cardiovascular Disease Business (2017-2022)
11.12.5 AnGes Recent Developments
11.13 Orchard Therapeutics
11.13.1 Orchard Therapeutics Company Details
11.13.2 Orchard Therapeutics Business Overview
11.13.3 Orchard Therapeutics Gene Therapy On Cardiovascular Disease Introduction
11.13.4 Orchard Therapeutics Revenue in Gene Therapy On Cardiovascular Disease Business (2017-2022)
11.13.5 Orchard Therapeutics Recent Developments
11.14 Human Stem Cells Institute
11.14.1 Human Stem Cells Institute Company Details
11.14.2 Human Stem Cells Institute Business Overview
11.14.3 Human Stem Cells Institute Gene Therapy On Cardiovascular Disease Introduction
11.14.4 Human Stem Cells Institute Revenue in Gene Therapy On Cardiovascular Disease Business (2017-2022)
11.14.5 Human Stem Cells Institute Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Gene Therapy On Cardiovascular Disease Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Viral Gene Therapy
Table 3. Key Players of Non-Viral Gene Therapy
Table 4. Global Gene Therapy On Cardiovascular Disease Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 5. Global Gene Therapy On Cardiovascular Disease Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Gene Therapy On Cardiovascular Disease Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global Gene Therapy On Cardiovascular Disease Market Share by Region (2017-2022)
Table 8. Global Gene Therapy On Cardiovascular Disease Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global Gene Therapy On Cardiovascular Disease Market Share by Region (2023-2028)
Table 10. Gene Therapy On Cardiovascular Disease Market Trends
Table 11. Gene Therapy On Cardiovascular Disease Market Drivers
Table 12. Gene Therapy On Cardiovascular Disease Market Challenges
Table 13. Gene Therapy On Cardiovascular Disease Market Restraints
Table 14. Global Gene Therapy On Cardiovascular Disease Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global Gene Therapy On Cardiovascular Disease Revenue Share by Players (2017-2022)
Table 16. Global Top Gene Therapy On Cardiovascular Disease by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapy On Cardiovascular Disease as of 2021)
Table 17. Ranking of Global Top Gene Therapy On Cardiovascular Disease Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by Gene Therapy On Cardiovascular Disease Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Gene Therapy On Cardiovascular Disease Product Solution and Service
Table 21. Date of Enter into Gene Therapy On Cardiovascular Disease Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Gene Therapy On Cardiovascular Disease Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global Gene Therapy On Cardiovascular Disease Revenue Market Share by Type (2017-2022)
Table 25. Global Gene Therapy On Cardiovascular Disease Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global Gene Therapy On Cardiovascular Disease Revenue Market Share by Type (2023-2028)
Table 27. Global Gene Therapy On Cardiovascular Disease Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global Gene Therapy On Cardiovascular Disease Revenue Share by Application (2017-2022)
Table 29. Global Gene Therapy On Cardiovascular Disease Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global Gene Therapy On Cardiovascular Disease Revenue Share by Application (2023-2028)
Table 31. North America Gene Therapy On Cardiovascular Disease Market Size by Type (2017-2022) & (US$ Million)
Table 32. North America Gene Therapy On Cardiovascular Disease Market Size by Type (2023-2028) & (US$ Million)
Table 33. North America Gene Therapy On Cardiovascular Disease Market Size by Application (2017-2022) & (US$ Million)
Table 34. North America Gene Therapy On Cardiovascular Disease Market Size by Application (2023-2028) & (US$ Million)
Table 35. North America Gene Therapy On Cardiovascular Disease Market Size by Country (2017-2022) & (US$ Million)
Table 36. North America Gene Therapy On Cardiovascular Disease Market Size by Country (2023-2028) & (US$ Million)
Table 37. Europe Gene Therapy On Cardiovascular Disease Market Size by Type (2017-2022) & (US$ Million)
Table 38. Europe Gene Therapy On Cardiovascular Disease Market Size by Type (2023-2028) & (US$ Million)
Table 39. Europe Gene Therapy On Cardiovascular Disease Market Size by Application (2017-2022) & (US$ Million)
Table 40. Europe Gene Therapy On Cardiovascular Disease Market Size by Application (2023-2028) & (US$ Million)
Table 41. Europe Gene Therapy On Cardiovascular Disease Market Size by Country (2017-2022) & (US$ Million)
Table 42. Europe Gene Therapy On Cardiovascular Disease Market Size by Country (2023-2028) & (US$ Million)
Table 43. Asia Pacific Gene Therapy On Cardiovascular Disease Market Size by Type (2017-2022) & (US$ Million)
Table 44. Asia Pacific Gene Therapy On Cardiovascular Disease Market Size by Type (2023-2028) & (US$ Million)
Table 45. Asia Pacific Gene Therapy On Cardiovascular Disease Market Size by Application (2017-2022) & (US$ Million)
Table 46. Asia Pacific Gene Therapy On Cardiovascular Disease Market Size by Application (2023-2028) & (US$ Million)
Table 47. Asia Pacific Gene Therapy On Cardiovascular Disease Market Size by Region (2017-2022) & (US$ Million)
Table 48. Asia Pacific Gene Therapy On Cardiovascular Disease Market Size by Region (2023-2028) & (US$ Million)
Table 49. Latin America Gene Therapy On Cardiovascular Disease Market Size by Type (2017-2022) & (US$ Million)
Table 50. Latin America Gene Therapy On Cardiovascular Disease Market Size by Type (2023-2028) & (US$ Million)
Table 51. Latin America Gene Therapy On Cardiovascular Disease Market Size by Application (2017-2022) & (US$ Million)
Table 52. Latin America Gene Therapy On Cardiovascular Disease Market Size by Application (2023-2028) & (US$ Million)
Table 53. Latin America Gene Therapy On Cardiovascular Disease Market Size by Country (2017-2022) & (US$ Million)
Table 54. Latin America Gene Therapy On Cardiovascular Disease Market Size by Country (2023-2028) & (US$ Million)
Table 55. Middle East and Africa Gene Therapy On Cardiovascular Disease Market Size by Type (2017-2022) & (US$ Million)
Table 56. Middle East and Africa Gene Therapy On Cardiovascular Disease Market Size by Type (2023-2028) & (US$ Million)
Table 57. Middle East and Africa Gene Therapy On Cardiovascular Disease Market Size by Application (2017-2022) & (US$ Million)
Table 58. Middle East and Africa Gene Therapy On Cardiovascular Disease Market Size by Application (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Gene Therapy On Cardiovascular Disease Market Size by Country (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Gene Therapy On Cardiovascular Disease Market Size by Country (2023-2028) & (US$ Million)
Table 61. Biogen Company Details
Table 62. Biogen Business Overview
Table 63. Biogen Gene Therapy On Cardiovascular Disease Product
Table 64. Biogen Revenue in Gene Therapy On Cardiovascular Disease Business (2017-2022) & (US$ Million)
Table 65. Biogen Recent Developments
Table 66. Novartis Company Details
Table 67. Novartis Business Overview
Table 68. Novartis Gene Therapy On Cardiovascular Disease Product
Table 69. Novartis Revenue in Gene Therapy On Cardiovascular Disease Business (2017-2022) & (US$ Million)
Table 70. Novartis Recent Developments
Table 71. Gilead Sciences Company Details
Table 72. Gilead Sciences Business Overview
Table 73. Gilead Sciences Gene Therapy On Cardiovascular Disease Product
Table 74. Gilead Sciences Revenue in Gene Therapy On Cardiovascular Disease Business (2017-2022) & (US$ Million)
Table 75. Gilead Sciences Recent Developments
Table 76. Sarepta Therapeutics Company Details
Table 77. Sarepta Therapeutics Business Overview
Table 78. Sarepta Therapeutics Gene Therapy On Cardiovascular Disease Product
Table 79. Sarepta Therapeutics Revenue in Gene Therapy On Cardiovascular Disease Business (2017-2022) & (US$ Million)
Table 80. Sarepta Therapeutics Recent Developments
Table 81. Alnylam Pharmaceuticals Company Details
Table 82. Alnylam Pharmaceuticals Business Overview
Table 83. Alnylam Pharmaceuticals Gene Therapy On Cardiovascular Disease Product
Table 84. Alnylam Pharmaceuticals Revenue in Gene Therapy On Cardiovascular Disease Business (2017-2022) & (US$ Million)
Table 85. Alnylam Pharmaceuticals Recent Developments
Table 86. Amgen Company Details
Table 87. Amgen Business Overview
Table 88. Amgen Gene Therapy On Cardiovascular Disease Product
Table 89. Amgen Revenue in Gene Therapy On Cardiovascular Disease Business (2017-2022) & (US$ Million)
Table 90. Amgen Recent Developments
Table 91. Spark Therapeutics Company Details
Table 92. Spark Therapeutics Business Overview
Table 93. Spark Therapeutics Gene Therapy On Cardiovascular Disease Product
Table 94. Spark Therapeutics Revenue in Gene Therapy On Cardiovascular Disease Business (2017-2022) & (US$ Million)
Table 95. Spark Therapeutics Recent Developments
Table 96. Akcea Therapeutics Company Details
Table 97. Akcea Therapeutics Business Overview
Table 98. Akcea Therapeutics Gene Therapy On Cardiovascular Disease Product
Table 99. Akcea Therapeutics Revenue in Gene Therapy On Cardiovascular Disease Business (2017-2022) & (US$ Million)
Table 100. Akcea Therapeutics Recent Developments
Table 101. bluebird bio Company Details
Table 102. bluebird bio Business Overview
Table 103. bluebird bio Gene Therapy On Cardiovascular Disease Product
Table 104. bluebird bio Revenue in Gene Therapy On Cardiovascular Disease Business (2017-2022) & (US$ Million)
Table 105. bluebird bio Recent Developments
Table 106. Sunway Biotech Company Details
Table 107. Sunway Biotech Business Overview
Table 108. Sunway Biotech Gene Therapy On Cardiovascular Disease Product
Table 109. Sunway Biotech Revenue in Gene Therapy On Cardiovascular Disease Business (2017-2022) & (US$ Million)
Table 110. Sunway Biotech Recent Developments
Table 111. SIBIONO Company Details
Table 112. SIBIONO Business Overview
Table 113. SIBIONO Gene Therapy On Cardiovascular Disease Product
Table 114. SIBIONO Revenue in Gene Therapy On Cardiovascular Disease Business (2017-2022) & (US$ Million)
Table 115. SIBIONO Recent Developments
Table 116. AnGes Company Details
Table 117. AnGes Business Overview
Table 118. AnGes Gene Therapy On Cardiovascular Disease Product
Table 119. AnGes Revenue in Gene Therapy On Cardiovascular Disease Business (2017-2022) & (US$ Million)
Table 120. AnGes Recent Developments
Table 121. Orchard Therapeutics Company Details
Table 122. Orchard Therapeutics Business Overview
Table 123. Orchard Therapeutics Gene Therapy On Cardiovascular Disease Product
Table 124. Orchard Therapeutics Revenue in Gene Therapy On Cardiovascular Disease Business (2017-2022) & (US$ Million)
Table 125. Orchard Therapeutics Recent Developments
Table 126. Human Stem Cells Institute Company Details
Table 127. Human Stem Cells Institute Business Overview
Table 128. Human Stem Cells Institute Gene Therapy On Cardiovascular Disease Product
Table 129. Human Stem Cells Institute Revenue in Gene Therapy On Cardiovascular Disease Business (2017-2022) & (US$ Million)
Table 130. Human Stem Cells Institute Recent Developments
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Gene Therapy On Cardiovascular Disease Market Share by Type: 2021 VS 2028
Figure 2. Viral Gene Therapy Features
Figure 3. Non-Viral Gene Therapy Features
Figure 4. Global Gene Therapy On Cardiovascular Disease Market Share by Application: 2021 VS 2028
Figure 5. Heart Disease Case Studies
Figure 6. Vascular Disease Case Studies
Figure 7. Gene Therapy On Cardiovascular Disease Report Years Considered
Figure 8. Global Gene Therapy On Cardiovascular Disease Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 9. Global Gene Therapy On Cardiovascular Disease Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 10. Global Gene Therapy On Cardiovascular Disease Market Share by Region: 2021 VS 2028
Figure 11. Global Gene Therapy On Cardiovascular Disease Market Share by Players in 2021
Figure 12. Global Top Gene Therapy On Cardiovascular Disease Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapy On Cardiovascular Disease as of 2021)
Figure 13. The Top 10 and 5 Players Market Share by Gene Therapy On Cardiovascular Disease Revenue in 2021
Figure 14. North America Gene Therapy On Cardiovascular Disease Market Size YoY (2017-2028) & (US$ Million)
Figure 15. North America Gene Therapy On Cardiovascular Disease Market Size Market Share by Type (2017-2028)
Figure 16. North America Gene Therapy On Cardiovascular Disease Market Size Market Share by Application (2017-2028)
Figure 17. North America Gene Therapy On Cardiovascular Disease Market Size Share by Country (2017-2028)
Figure 18. United States Gene Therapy On Cardiovascular Disease Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 19. Canada Gene Therapy On Cardiovascular Disease Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Europe Gene Therapy On Cardiovascular Disease Market Size YoY (2017-2028) & (US$ Million)
Figure 21. Europe Gene Therapy On Cardiovascular Disease Market Size Market Share by Type (2017-2028)
Figure 22. Europe Gene Therapy On Cardiovascular Disease Market Size Market Share by Application (2017-2028)
Figure 23. Europe Gene Therapy On Cardiovascular Disease Market Size Share by Country (2017-2028)
Figure 24. Germany Gene Therapy On Cardiovascular Disease Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. France Gene Therapy On Cardiovascular Disease Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. U.K. Gene Therapy On Cardiovascular Disease Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Italy Gene Therapy On Cardiovascular Disease Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Russia Gene Therapy On Cardiovascular Disease Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Nordic Countries Gene Therapy On Cardiovascular Disease Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Asia-Pacific Gene Therapy On Cardiovascular Disease Market Size YoY (2017-2028) & (US$ Million)
Figure 31. Asia Pacific Gene Therapy On Cardiovascular Disease Market Size Market Share by Type (2017-2028)
Figure 32. Asia Pacific Gene Therapy On Cardiovascular Disease Market Size Market Share by Application (2017-2028)
Figure 33. Asia Pacific Gene Therapy On Cardiovascular Disease Market Size Share by Region (2017-2028)
Figure 34. China Gene Therapy On Cardiovascular Disease Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Japan Gene Therapy On Cardiovascular Disease Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. South Korea Gene Therapy On Cardiovascular Disease Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Southeast Asia Gene Therapy On Cardiovascular Disease Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. India Gene Therapy On Cardiovascular Disease Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Australia Gene Therapy On Cardiovascular Disease Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Latin America Gene Therapy On Cardiovascular Disease Market Size YoY (2017-2028) & (US$ Million)
Figure 41. Latin America Gene Therapy On Cardiovascular Disease Market Size Market Share by Type (2017-2028)
Figure 42. Latin America Gene Therapy On Cardiovascular Disease Market Size Market Share by Application (2017-2028)
Figure 43. Latin America Gene Therapy On Cardiovascular Disease Market Size Share by Country (2017-2028)
Figure 44. Mexico Gene Therapy On Cardiovascular Disease Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. Brazil Gene Therapy On Cardiovascular Disease Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. Middle East & Africa Gene Therapy On Cardiovascular Disease Market Size YoY (2017-2028) & (US$ Million)
Figure 47. Middle East and Africa Gene Therapy On Cardiovascular Disease Market Size Market Share by Type (2017-2028)
Figure 48. Middle East and Africa Gene Therapy On Cardiovascular Disease Market Size Market Share by Application (2017-2028)
Figure 49. Middle East and Africa Gene Therapy On Cardiovascular Disease Market Size Share by Country (2017-2028)
Figure 50. Turkey Gene Therapy On Cardiovascular Disease Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 51. Saudi Arabia Gene Therapy On Cardiovascular Disease Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 52. UAE Gene Therapy On Cardiovascular Disease Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 53. Biogen Revenue Growth Rate in Gene Therapy On Cardiovascular Disease Business (2017-2022)
Figure 54. Novartis Revenue Growth Rate in Gene Therapy On Cardiovascular Disease Business (2017-2022)
Figure 55. Gilead Sciences Revenue Growth Rate in Gene Therapy On Cardiovascular Disease Business (2017-2022)
Figure 56. Sarepta Therapeutics Revenue Growth Rate in Gene Therapy On Cardiovascular Disease Business (2017-2022)
Figure 57. Alnylam Pharmaceuticals Revenue Growth Rate in Gene Therapy On Cardiovascular Disease Business (2017-2022)
Figure 58. Amgen Revenue Growth Rate in Gene Therapy On Cardiovascular Disease Business (2017-2022)
Figure 59. Spark Therapeutics Revenue Growth Rate in Gene Therapy On Cardiovascular Disease Business (2017-2022)
Figure 60. Akcea Therapeutics Revenue Growth Rate in Gene Therapy On Cardiovascular Disease

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029

Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118

The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......

Global Non-imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90

The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......

Global PCR Equipment Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77

The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......

Global Disposable Sterile Syringes and Needles Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109

The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......

Global Orthopaedic Power Tools Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......

Global Cerebrospinal Fluid Management Devices Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......

Global CAD & CAM Milling Burs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......

Global Artificial Teeth Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98

The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs